Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Glycolytic Pathway as a Target for Novel Onco-Immunology Therapies in Pancreatic Cancer

15 Mar 2021

Abstract excerpt

Pancreatic ductal adenocarcinoma (PDA) is one of the most lethal forms of human cancer, characterized by unrestrained progression, invasiveness and treatment resistance. To date, there are limited curative options, with surgical resection as the only effective strategy, hence the urgent need to discover novel therapies. A platform of onco-immunology targets is represented by molecules that play a role in the...

Topics

Join the communities discussing this publication.

Cancer, Hypoxia, and Metabolism
Cancer Research and Treatments
Neuroblastoma Research and Treatments

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33804240
DOI: 10.3390/molecules26061642

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Glycolytic Pathway as a Target for Novel Onco-Immunology Therapies in Pancreatic CancerPMID 33804240Read ↗

Cellular metabolism in pancreatic cancer as a tool for prognosis and treatment (Review)Semantic proximity Read ↗

Metabolic reprogramming by driver mutation-tumor microenvironment interplay in pancreatic cancer: new therapeutic targets.Semantic proximity Read ↗

Tumor–stromal metabolic crosstalk in pancreatic cancerSemantic proximity Read ↗

The complex landscape of pancreatic cancer metabolismSemantic proximity Read ↗

Glycometabolic rearrangements–aerobic glycolysis in pancreatic ductal adenocarcinoma (PDAC): roles, regulatory networks, and therapeutic potentialSemantic proximity Read ↗

Energy sources identify metabolic phenotypes in pancreatic cancer.Semantic proximity Read ↗

[A Review of Metabolic Stress and Development of Pancreatic Cancer].Semantic proximity Read ↗

Molecular and Metabolic Subtypes Correspondence for Pancreatic Ductal Adenocarcinoma ClassificationSemantic proximity Read ↗

Establishment and Verification of a Novel Gene Signature Connecting Hypoxia and Lactylation for Predicting Prognosis and Immunotherapy of Pancreatic Ductal Adenocarcinoma Patients by Integrating Multi-Machine Learning and Single-Cell AnalysisSemantic proximity Read ↗

Metabolic reprogramming shapes the immune microenvironment in pancreatic adenocarcinoma: prognostic implications and therapeutic targetsSemantic proximity Read ↗

Glucose metabolic phenotype of pancreatic cancer.Semantic proximity Read ↗

The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectivesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.